跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,664 条关于
“CKD-aP”
全部
4,664
临床试验
3,403
药物
807
机构
26
资讯
428
12个月前
Expert Commentary Questions HSK21542 Efficacy Claims for Chronic Kidney Disease-Associated Pruritus
去年
FDA Approves Ozempic for Reducing Kidney Disease Risks in Type 2 Diabetes Patients
去年
Lubiprostone Shows Promise in Slowing Kidney Function Decline in Phase II CKD Trial
去年
Dapagliflozin Approved by FDA to Reduce Cardiovascular and Renal Risks in CKD Patients
去年
Tirzepatide Shows Significant Kidney Function Improvement in Patients with Obesity and Heart Failure
去年
Semaglutide Shows Promise in Reducing Albuminuria in Non-Diabetic Kidney Disease
2年前
EASi-KIDNEY Trial Investigates Vicadrostat for Chronic Kidney Disease
去年
AstraZeneca and Aptar Digital Health Partner to Develop AI Algorithms for Early Detection of Chronic Kidney Disease
10个月前
Chong Kun Dang Showcases Three Promising Drug Candidates at Major U.S. Medical Conferences
去年
FDA Expands Furoscix Approval to Include Edema Treatment in CKD Patients
第 1 页,共 43 页
上一页
下一页